Molecular mechanisms of cerebral vasospasm following aneurysmal SAH

Neurological Research

Volumn 29, Issue 7, 2007, Pages 636-642

  Rothoerl, Ralf Dirk ^a   Ringel, Florian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Pathophysiology; SAII; Vasospasm

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; G PROTEIN COUPLED RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; VASCULAR CELL ADHESION MOLECULE 1;

ANEURYSM; BLOOD VESSEL TONE; BRAIN DAMAGE; BRAIN VASOSPASM; CALCIUM CELL LEVEL; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HUMAN; INFLAMMATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SMOOTH MUSCLE CONTRACTILITY; SUBARACHNOID HEMORRHAGE;

ANIMALS; CEREBRAL ARTERIES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 36049033130     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X240224     Document Type: Review

References (76)

1. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 2003; 53: 123-133
2. Macdonald L. Molecular mediators of hemorrhagic stroke. In: Freese A, Simeone FA, Leone P, Janson C, eds. Principles of Molecular Neurosurgery, Basel: Kager, 2005: pp. 377-412
3. Bulter WE, Peterson JW, Zervas NT, et al. Intracellular calcium, myosin light chain phosphorylation, and contractile force in experimental cerebral vasospasm. Neurosurgery 1996; 38: 781-787
4. Sato M, Tani E, Fujikawa H, et al. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000; 87: 195-200
5. Fujikawa H, Tani E, Yamaura I, et al. Activation of protein kinases in canine basilar artery in vasospasm. J Cereb Blood Flow Metab 1999; 19: 44-52
6. + channel activator cromakalim. Stroke 1996; 27: 311-316
7. Harder DR, Dernbach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 1987; 80: 875-880
8. Miyagi Y, Kobayashi S, Nishimura J, et al. Resting load regulates cytosolic calcium-force relationship of the contraction of bovine cerebrovascular smooth muscle. J Physiol 1995; 484: 123-137
9. Miyagi Y, Carpenter RC, Meguro T, et al. Upregulation of Rho A and Rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg 2000; 93: 471-476
10. Lan C, Das D, Wloskowicz A, et al. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol 2004; 286: H165-H173
11. Satoh M, Parent AD, Zhang JH. Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats. Stroke 2002; 33: 775-781
12. Tibbs R, Zubkov A, Aoki K, et al. Effects of mitogen-activated protein kinase inhibitors on cerebral vasospasm in a double-hemorrhage model in dogs. J Neurosurg 2000; 93: 1041-1047
13. Zubkov AY, Tibbs RE, Aoki K, et al. Prevention of vasospasm in penetrating arteries with MAPK inhibitors in dog double-hemorrhage model. Surg Neurol 2000; 54: 221-227
14. Kusaka G, Kimura H, Kusaka I, et al. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2003; 99: 383-390
15. Kusaka G, Ishikawa M, Nanda A, et al. Signaling pathways for early brain injury after SAH. J Cereb Blood Flow Metab 2004; 24: 916-925
16. Faraci FM, Heistad DD. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 1998; 78: 53-97
17. Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg 2000; 92: 390-400
18. Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 97: 1287-1293
19. Kanamaru K, Waga S, Fujimoto K, et al. Endothelium-dependent relaxation of human basilar arteries. Stroke 1989; 20: 1208-1211
20. Kim P, Lorenz RR, Sundt TM, Jr, et al. Release of endothelium-derived relaxing factor after SAH. J Neurosurg 1989; 70: 108-114
21. Kim P, Sundt TM, Jr, Vanhoutte PM. Alterations in endothelium-dependent responsiveness of the canine basilar artery subarachnoid hemorrhage. J Neurosurg 1988; 69: 239-246
22. Roman RJ, Gebremedhin D, Birks EK, et al. A common pathway for regulation of nutritive blood flow to the brain: Arterial muscle membrane potential and cytochrome P450 metabolites. Acta Physiol Scand 1998; 164: 527-532
23. Sayama T, Inamura T, Matsushima T, et al. High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms. Neurol Res 2000; 22: 151-155
24. Sayama T, Suzuki S, Fukui M. Role of inducible nitric oxide synthase in the cerebral vasospasm after subarachnoid hemorrhage in rats. Neurol Res 1999; 21: 293-298
25. Seifert V, Loffler BM, Zimmermann M, et al. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 1995; 82: 55-62
26. Suzuki R, Masaoka H, Hirata Y, et al. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1992; 77: 96-100
27. Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 2005; 103: 9-17
28. Yamamoto S, Nishizawa S, Yokoyama T, et al. Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries. Brain Res 1997; 757: 1-9
29. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 1999; 43: 639-649
30. Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: An overview. Neurosurgery 1998; 43: 863-875
31. Arfors KE, Lundberg C, Lindbom L, et al. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 1987; 69: 338-340
32. Bavbek M, Polin R, Kwan A, et al. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998; 29: 1930-1936
33. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-1036
34. Crompton MR. The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 1964; 87: 491-510
35. Findlay JM, Weir BK, Kanamaru K, et al. Arterial wall changes in cerebral vasospasm. Neurosurgery 1989; 25: 736-746
36. Hammer DA, Apte SM. Simulation of cell rolling and adhesion on surfaces in shear flow: General results and analysis of selectin-mediated neutrophil adhesion. Biophys J 1992; 63: 35-57
37. Handa Y, Kubota T, Kaneko M, et al. Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid hemorrhage in rats. Acta Neurochir (Wien) 1995; 132: 92-97
38. Hughes JT, Schianchi PM. Cerebral artery spasm: A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978; 48: 515-525
39. Iigo Y, Suematsu M, Higashida T, et al. Constitutive expression of ICAM-1 in rat microvascular systems analyzed by laser confocal microscopy. Am J Physiol 1997; 273: H138-H147
40. Khurana VG, Fox DJ, Meissner I, et al. Update on evidence for a genetic predisposition to cerebral vasospasm. Neurosurg Focus 2006; 21: E3
41. Kubota T, Handa Y, Tsuchida A, et al. The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke 1993; 24: 1993-2001
42. Laukkanen MO, Kivela A, Rissanen T, et al. Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2002; 106: 1999-2003
43. Ley K. Granulocyte adhesion to microvascular and cultured endothelium. Studia Biophys 1989; 134: 179-184
44. Oshiro EM, Hoffman PA, Dietsch GN, et al. Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke 1997; 28: 2031-2038
45. Rothoerl RD, Axmann C, Pina AL, et al. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2006; 18: 68-72
46. Rothoerl RD, Schebesch KM, Kubitza M, et al. ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits. Cerebrovasc Dis 2006; 22: 143-149
47. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827-872
48. Thai Q, Oshiro EM, Tamargo RJ. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 1999; 30: 140-147
49. Tsementzis SA, Chao SW, Hitchcock ER, et al. Oligoclonal immunoglobulin G in acute subarachnoid hemorrhage and stroke. Neurology 1986; 36: 395-397
50. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-1141
51. Weir B, Erasmo R, Miller J, et al. Vasospasm in response to repeated subarachnoid hemorrhages in the monkey. J Neurosurg 1970; 33: 395-406
52. Mima T, Mostafa MG, Mori K. Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl 1997; 70: 65-67
53. Macdonald RL, Zhang ZD, Ono S, et al. Up-regulation of parathyroid hormone receptor in cerebral arteries after subarachnoid hemorrhage in monkeys. Neurosurgery 2002; 50: 1083-1091
54. Kasuya H, Weir B, Shen Y, et al. Procollagen types I and III and transforming growth factor-beta gene expression in the arterial wall after exposure to periarterial blood. Neurosurgery 1993; 33: 716-721
55. Aihara Y, Kasuya H, Onda H, et al. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 2001; 32: 212-217
56. Onoda K, Ono S, Ogihara K, et al. Role of extracellular matrix in experimental vasospasm. Inhibitory effect of antisense oligonucleotide on collagen induction. Stroke 1996; 27: 2102-2108
57. Vikman P, Beg S, Khurana T, et al. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg 2006; 105: 438-444
58. Sasaki T, Kasuya H, Onda H, et al. Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage. Stroke 2004; 35: 1466-1470
59. Onda H, Kasuya H, Takakura K, et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1999; 19: 1279-1288
60. Nikaido H, Tsunoda H, Nishimura Y, et al. Potential role for heat shock protein 72 in antagonizing cerebral vasospasm after rat subarachnoid hemorrhage. Circulation 2004; 110: 1839-1846
61. Sayama T, Suzuki S, Fukui M. Expression of inducible nitric oxide synthase in rats following subarachnoid hemorrhage. Neurol Res 1998; 20: 79-84
62. Shih HC, Lin CL, Lee TY, et al. 17beta-Estradiol inhibits subarachnoid hemorrhage-induced inducible nitric oxide synthase gene expression by interfering with the nuclear factor kappa B transactivation. Stroke 2006; 37: 3025-3031
63. Saito A, Kamii H, Kato I, et al. Transgenic CuZn-superoxide dismutase inhibits nitric oxide synthase induction in experimental subarachnoid hemorrhage. Stroke 2001; 32: 1652-1657
64. Widenka DC, Medele RJ, Stummer W, et al. Inducible nitric oxide synthase: A possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 1999; 90: 1098-1104
65. Hino A, Tokuyama Y, Weir B, et al. Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 1996; 39: 562-567
66. Marton LS, Wang X, Kowalczuk A, et al. Effects of hemoglobin on heme oxygenase gene expression and viability of cultured smooth muscle cells. Am J Physiol Heart Circ Physiol 2000; 279: H2405-H2413
67. Suzuki H, Kanamaru K, Tsunoda H, et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 1999; 104: 59-66
68. Hino A, Tokuyama Y, Kobayashi M, et al. Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 1996; 16: 688-697
69. B receptor contractile activity in rat cerebral artery. Neuroreport 1999; 10: 2355-2359
70. Hansen-Schwartz J, Hoel NL, Zhou M, et al. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003; 52: 1188-1194
71. A receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 1994; 81: 759-764
72. Hansen-Schwartz J. Receptor changes in cerebral arteries after subarachnoid haemorrhage. Acta Neurol Scand 2004; 109: 33-44
73. 1B receptor in cerebral arteries in rats. J Neurosurg 2003; 99: 115-120
74. Carpenter RC, Miao L, Miyagi Y, et al. Altered expression of P2 receptor mRNAs in the basilar artery in a rat double hemorrhage model. Stroke 2001; 32: 516-522
75. Beg SA, Hansen-Schwartz JA, Vikman PJ, et al. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after SAH in rat. J Cereb Blood Flow Metab 2006; 26: 846-856
76. Beg SS, Hansen-Schwartz JA, Vikman PJ, et al. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J Cereb Blood Flow Metab 2007; 27: 21-32